Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Peripheral Blood Stem Cell Transplantation 36fludarabine phosphate 33Cyclophosphamide 31Mycophenolic Acid 26Whole-Body Irradiation 23Tacrolimus 22Cyclosporine 19Radiotherapy 16Busulfan 16Antilymphocyte Serum 15Methotrexate 14Filgrastim 12Etoposide 12Flow Cytometry 11Rituximab 8Methylprednisolone 8Melphalan 8Brentuximab Vedotin 8pembrolizumab 7Therapeutics 7Lenalidomide 7Bortezomib 7Psychiatric Rehabilitation 6Gemcitabine 6Cord Blood Stem Cell Transplantation 6Bexarotene 6romidepsin 5mogamulizumab 5fludarabine 5Transplantation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mycosis Fungoides × hypericin × Clear all
NCT05872854 2026-02-09

RW-HPN-MF-01

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
10 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡